| Date Filed | Type | Description |
| 07/18/2023 |
8-K
| Filed for Chapter 11 |
| 05/15/2023 |
8-K
| Results of Operations and Financial Condition Interactive Data |
| 05/15/2023 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 05/12/2023 |
8-K
| Filed for Chapter 11|
Docs:
|
"Asset Purchase Agreement, between Allied Healthcare Products, Inc. and Allied Medical, LLC",
"Asset Purchase Agreement, between Allied Healthcare Products, Inc. and Allied Medical, LLC",
"Debtor-In-Possession Loan Agreement, between Sterling Commercial Credit, LLC and Allied Healthcare Products, Inc",
"Allied Healthcare Products Enters into Asset Purchase Agreement and Commences Voluntary Chapter 11 Proceedings to Facilitate Value Maximizing Sale" |
|
| 03/16/2023 |
8-K
| Entry into a Material Definitive Agreement, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an... |
| 02/27/2023 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of... |
| 02/14/2023 |
8-K
| Results of Operations and Financial Condition Interactive Data |
| 02/14/2023 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 02/08/2023 |
8-K
| Quarterly results |
| 01/31/2023 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive Data |
| 01/26/2023 |
8-K
| Cost Associated with Exit or Disposal Activities, Material Impairments, Notice of Delisting or Failure to Satisfy a Continued... |
| 01/11/2023 |
8-K
| Other Events Interactive Data |
| 12/22/2022 |
8-K
| Quarterly results |
| 12/13/2022 |
8-K
| Quarterly results |
| 11/28/2022 |
8-K
| Quarterly results |
| 11/15/2022 |
8-K
| Quarterly results |
| 11/14/2022 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 11/14/2022 |
8-K
| Quarterly results |
| 10/12/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 10/07/2022 |
10-K
| Annual Report for the period ended June 30, 2022 |
| 09/28/2022 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 06/22/2022 |
8-K
| Quarterly results |
| 06/14/2022 |
8-K
| Quarterly results |
| 05/16/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 02/14/2022 |
10-Q
| Quarterly Report for the period ended December 31, 2021 |
| 12/02/2021 |
SC 13D/A
| WEIL JOHN D reports a 5% stake in Allied Healthcare Products, Inc. |
| 11/30/2021 |
4
| WEIL JOHN D (Director) has filed a Form 4 on ALLIED HEALTHCARE PRODUCTS INC|
Txns:
| Sold 69,249 shares
@ $8.437, valued at
$584.3k
Sold 59,101 shares
@ $8.467, valued at
$500.4k
Sold 7,514 shares
@ $8.0565, valued at
$60.5k
Granted 750 options to buy
@ $5.09, valued at
$3.8k
|
|
| 11/30/2021 |
SC 13D/A
| WEIL JOHN D reports a 4.5% stake in Allied Healthcare Products, Inc. |
| 11/15/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
| 11/15/2021 |
4
| Root Joseph Ernest JR (Director) has filed a Form 4 on ALLIED HEALTHCARE PRODUCTS INC|
Txns:
| Granted 750 options to buy
@ $5.09, valued at
$3.8k
|
|
| 11/15/2021 |
4
| GRAVES JUDY T (Director) has filed a Form 4 on ALLIED HEALTHCARE PRODUCTS INC|
Txns:
| Granted 750 options to buy
@ $5.09, valued at
$3.8k
|
|
| 11/15/2021 |
4
| Deuser Susan M (Director) has filed a Form 4 on ALLIED HEALTHCARE PRODUCTS INC|
Txns:
| Granted 750 options to buy
@ $5.09, valued at
$3.8k
|
|
| 11/15/2021 |
4
| WEIL JOHN D (Director) has filed a Form 4 on ALLIED HEALTHCARE PRODUCTS INC|
Txns:
| Granted 750 options to buy
@ $5.09, valued at
$3.8k
|
|
| 11/12/2021 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
|